These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 19380070

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA, Pregabalin 1008-009 Study Group.
    Neurology; 2005 Feb 08; 64(3):475-80. PubMed ID: 15699378
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U, Spalice A, Basile LA, Guardalà C, Nasta L, Terenzi S, Iannetti P.
    Pediatr Med Chir; 1994 Feb 08; 16(6):575-8. PubMed ID: 7708543
    [Abstract] [Full Text] [Related]

  • 5. Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trials.
    Uthman BM, Bazil CW, Beydoun A, Schulze-Bonhage A, Benabou R, Whalen E, Emir B, Griesing T, Leon T.
    Epilepsia; 2010 Jun 08; 51(6):968-78. PubMed ID: 20345940
    [Abstract] [Full Text] [Related]

  • 6. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM, Almas M, Emir B, Giordano S, Leon T.
    Curr Med Res Opin; 2011 Jul 08; 27(7):1285-93. PubMed ID: 21561392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico).
    Rivera-Castaño L, Leal-Cantu R, Abreu P, Guerrero M, Davila G.
    Epilepsy Res; 2012 Jun 08; 100(1-2):74-9. PubMed ID: 22304935
    [Abstract] [Full Text] [Related]

  • 9. Pregabalin in partial seizures: a pragmatic 21-week, open-label study (PREPS).
    Ryvlin P, Kälviäinen R, Von Raison F, Giordano S, Emir B, Chatamra K.
    Eur J Neurol; 2010 May 08; 17(5):726-32. PubMed ID: 20113339
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability.
    Huber B, Bocchicchio M, Feuerbaum E, May T, Meinert T, Robertson E, Schorlemmer H, Wagner W, Wilking E, Seidel M.
    Epilepsy Behav; 2008 Aug 08; 13(2):397-401. PubMed ID: 18554985
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pregabalin as adjunctive therapy for partial seizures.
    Brodie MJ.
    Epilepsia; 2004 Aug 08; 45 Suppl 6():19-27. PubMed ID: 15315512
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Vigabatrin--a new antiepileptic agent].
    Nakken KO, Henriksen O, Johannessen SI.
    Tidsskr Nor Laegeforen; 1994 Oct 10; 114(24):2843-4. PubMed ID: 7998031
    [Abstract] [Full Text] [Related]

  • 17. Intravenous methylprednisolone for intractable childhood epilepsy.
    Almaabdi KH, Alshehri RO, Althubiti AA, Alsharef ZH, Mulla SN, Alshaer DS, Alfaidi NS, Jan MM.
    Pediatr Neurol; 2014 Apr 10; 50(4):334-6. PubMed ID: 24507698
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.